QIAGEN Aktie
WKN DE: A40ZZU / ISIN: NL0015002CX3
| 
15.01.2025 14:13:00
							 | 
					
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter 2024.
Press release date / time: Wednesday, February 5, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.
Conference call date / time: Thursday, February 6, at 16:00 Frankfurt time / 15:00 London time / 10:00 New York time.
Three options for joining the conference call
				Register for call back connection - Click here: Connect me 
Service is available 15 minutes before the call starts
				Dial-in by phone
U.S.: +1 646 828 8193
UK: +44 (0)330 165 4027
GER: +49 (0)69 6610 2480
Conference ID: 9237018
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Access the audio webcast - Click here: Access Webcast
A conference call replay will be available by using the following link:
https://event.webcasts.com/starthere.jsp?ei=1684130&tp_key=c56f1d6ba2
			
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of September 30, 2024, QIAGEN employed more than 5,800 people in over 35 locations worldwide. Further information can be found at https://www.qiagen.com.
Source: QIAGEN N.V.
Category: Financial
View source version on businesswire.com: https://www.businesswire.com/news/home/20250115503089/en/
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu QIAGEN N.V.mehr Nachrichten
| 
03.11.25 | 
							Gute Stimmung in Frankfurt: TecDAX zeigt sich letztendlich fester (finanzen.at) | |
| 
03.11.25 | 
							Zuversicht in Frankfurt: LUS-DAX legt zum Handelsende zu (finanzen.at) | |
| 
03.11.25 | 
							Zuversicht in Frankfurt: DAX bewegt sich zum Handelsende im Plus (finanzen.at) | |
| 
03.11.25 | 
							Freundlicher Handel in Frankfurt: TecDAX-Börsianer greifen nachmittags zu (finanzen.at) | |
| 
03.11.25 | 
							Aufschläge in Frankfurt: Am Nachmittag Pluszeichen im DAX (finanzen.at) | |
| 
03.11.25 | 
							LUS-DAX-Handel aktuell: LUS-DAX nachmittags mit Kursplus (finanzen.at) | |
| 
03.11.25 | 
							Börse Frankfurt: DAX am Montagmittag in Grün (finanzen.at) | |
| 
03.11.25 | 
							Gewinne in Frankfurt: LUS-DAX am Montagmittag mit Gewinnen (finanzen.at) | 
Analysen zu QIAGEN N.V.mehr Analysen
| 23.09.25 | QIAGEN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.25 | QIAGEN Buy | Jefferies & Company Inc. | |
| 20.08.25 | QIAGEN Buy | Deutsche Bank AG | |
| 07.08.25 | QIAGEN Buy | Jefferies & Company Inc. | |
| 06.08.25 | QIAGEN Buy | Deutsche Bank AG | 
Aktien in diesem Artikel
| QIAGEN N.V. | 39,29 | -0,70% | 
									 |